http://orcid.org/0000-0002-4807-8603
References
- Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S3–S6.
- Sickle-cell disease and other hemoglobin disorders. World Health Organization. Fact sheet No. 308, January 2011.
- Modell B, Khan M, Darlinson M, et al. Improved survival of thalassemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42. doi: 10.1186/1532-429X-10-42.
- Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89(3):739–761.
- Peters M, Heijboer H, Smiers F, et al. Diagnosis and management of thalassemia. Br Med J. 2012;344:e228. doi:10.1136/bmj.e228.
- Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
- Christiansen S, Gupta A. Can mobile technology improve treatment of chronic pain? Pain Med. 2014;15(8):1434–1435.
- Irvine AB, Russell H, Manocchia M, et al. Mobile-web app to self-manage low back pain: randomized controlled trial. J Med Internet Res. 2015;17:e1. doi: 10.2196/jmir.3130.
- Danes M, Whinder F. Diabetes management goes digital. Lancet Diabetes Endocrinol. 2013;1(1):17–18.
- Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the Life Windows Project. AIDS Behav. 2011;15(8):1635–1646.
- O’Hara DM, Seagriff-Curtin P, Levitz M, et al. Using Personal Digital Assistants to improve self-care in oral health. J Telemed Telecare. 2008;14(3):150–151.
- Borsci S, Federici S, Lauriola M. On the dimensionality of the System Usability Scase: a test of alternative measurement models. Cogn Process. 2009;10(3):193–197.
- Trachtenberg FL, Gestenberger E, Xu Y, et al. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res. 2014;23(8):2277–2288.
- Al-Kloub MI, Nayel Salameh T, Froelicher ES. Impact of psychosocial status and disease knowledge on deferoxamine adherence among thalassemia major adolescents. Int J Nurs Pract. 2014;20(3):265–274.
- Al-Kloub MI, A Bed MA, Al Khawaldeh OA, et al. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among Jordanian adolescents with Thalassemia major. Pediatr Hematol Oncol. 2014;31(7):624–637.
- Kuo KHM, Ward R. Application of self-efficacy theory in adherence to iron chelation therapy: a single-center cross-sectional study. Blood. 2011;118(21):5284. Available from: http://www.bloodjournal.org/content/118/21/5284?sso-checked=true
- Reeves G, Jauch LR. Curriculum development through Delphi. Res High Educ. 1978;8(2):157–168.